Journal
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 15, Issue 13, Pages 1052-1062Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557515666150709115355
Keywords
Apoptosis; Cell cycle checkpoints; DNA-Damage Response; DNA Repair; microRNAs; Tumor resistance
Categories
Funding
- University of Padova [60A06-3595/12]
Ask authors/readers for more resources
MicroRNAs (miRNAs), a recently discovered class of small non-coding RNAs, constitute a promising approach to anti-cancer treatments when they are used in combination with other agents. MiRNAs are evolutionarily conserved non-coding RNAs that negatively regulate gene expression by binding to the complementary sequence in the 3'-untranslated region (UTR) of target genes. MiRNAs typically suppress gene expression by direct association with target transcripts, thus decreasing the expression levels of target proteins. The delivery to cells of synthetic miRNAs that mimic endogenous miRNA targeting genes involved in the DNA-Damage Response (DDR) can perturb the process, making cells more sensitive to chemotherapy or radiotherapy. This review examines how cells respond to combined therapy and it provides insights into the role of miRNAs in targeting the DDR repair pathway when they are used in combination with chemical compounds or ionizing radiation to enhance cellular sensitivity to treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available